Our nation and economy are facing an unprecedented crisis.
We are committed to helping as many businesses, families and industries as possible endure the financial hardships caused by the pandemic and return to work in a safe and sustainable way.
The coronavirus pandemic prompted an unprecedented response from the nation’s business community. Now that safe and effective vaccines are available, the public- and private-sectors must rally around a common goal: vaccinate America.
Help for Small Businesses
Through the Save Small Business Initiative, the Chamber has been advocating for policies and aid to help companies stay afloat and keep paychecks flowing to American workers and families during this time.
Event Series from CO—
Each session in the CO— Roadmap for Rebuilding series will focus on a different topic of importance to business owners, and will offer valuable and practical tools you need to succeed. By taking this journey together, we'll recover and rebuild stronger than ever before.
Insight and Analysis
The reality of this pandemic is evolving every day and as businesses, communities, and government work together to combat new challenges that emerge as a result of COVID-19, we are providing the latest insights and analysis on the policies that will be most effective for our economy and our safety.
Event Series from U.S. Chamber Foundation
Explore topics ranging from big questions about immunity and liability to ways employers can incorporate innovative approaches to safety into the workplace. Featuring deep-dive conversations with a cross-sector of experts led by the U.S. Chamber of Commerce President Suzanne Clark, Path Forward airs weekly on Wednesdays at 3:00 p.m. ET.
- Oct 15, 2021
Arkansas Governor Asa Hutchison announced he will not sign nor veto the vaccine mandate exemption bills (Senate Bill 739/House Bill 1977) that were sent to his desk on October 13. The Governor‘s inaction will result in the companion bills becoming law in 90 days, barring judicial action.
- Oct 12, 2021
America is where innovation thrives, and cutting-edge medicine is no exception. Right now, scientists are conducting more than 140,000 clinical trials across all 50 states to explore the potential of the therapeutics, vaccines, diagnostics, and cures we need to fight disease—from coronavirus to cancer.